sábado, 6 de octubre de 2018

The biotech that snagged a deal with Roche without ever making a pitch - STAT

The biotech that snagged a deal with Roche without ever making a pitch - STAT



Daily Recap

STAT Plus: Startup Spotlight: This Cambridge biotech snagged a deal with Roche without ever making a pitch

By KATE SHERIDAN


ALEX HOGAN/STAT
GO Therapeutics announced Tuesday it had licensed antibodies for a particular cancer target to Roche. Rather than pitching themselves, Roche came to them.

No hay comentarios: